SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease.

Elkharsawi, Ahmed; Arnim, Ulrike von; Schmelz, Renate; Sander, Cornelia; Stallmach, Andreas; Teich, Niels; Walldorf, Jens; Reuken, Philipp A

Elkharsawi, Ahmed; Arnim, Ulrike von; Schmelz, Renate; Sander, Cornelia; Stallmach, Andreas; Teich, Niels; Walldorf, Jens; Reuken, Philipp A.

Affiliation

Elkharsawi A; Department of Internal Medicine IV, Jena University Hospital, Jena, Germany.
Arnim UV; Department of Gastroenterology, Hepatology and Infectious diseases, Universitätsklinikum Magdeburg AöR, Magdeburg, Germany.
Schmelz R; Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany.
Sander C; Deutsche Morbus Crohn/Colitis Ulcerosa Vereinigung e.V., Berlin, Germany.
Stallmach A; Department of Internal Medicine IV, Jena University Hospital, Jena, Germany.
Teich N; Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselkrankheiten, Leipzig, Germany.
Walldorf J; Department of Internal Medicine I, Martin Luther University Halle-Wittenberg, Halle, Germany.
Reuken PA; Department of Internal Medicine IV, Jena University Hospital, Jena, Germany.

Z Gastroenterol ; 60(1): 77-80, 2022 Jan.

Article de En | MEDLINE | ID: mdl-35042256

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladies inflammatoires intestinales / Colite / COVID-19 Limites: Humans Langue: En Journal: Z Gastroenterol Année: 2022 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google